TrialThe Journal of dermatology2021

Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial.

Shinichi Imafuku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.